Mayo Clinic Platform

growth-positive

CollPlant Biotechnologies, in collaboration with Mayo Clinic, has developed a fully humanized 3D bioprinted skin model using its plant-derived recombinant human collagen (rhCollagen). This innovative model serves as an alternative to animal testing for preclinical research and has potential applications in cosmetic and pharmaceutical testing, disease modeling, and drug development. The collaboration highlights the advantages of using rhCollagen-based bioinks for high-throughput production of personalized human skin models, which could significantly impact regenerative medicine. CollPlants partnership with Mayo Clinic and its existing agreement with Allergan for dermal and soft tissue fillers further solidify its position in the regenerative and aesthetic medicine market.